glp-1 microdose side effects Microdosing GLP-1s: Does It Work? Risks and Benefits Should You Microdose a GLP-1?

The efficiency of liraglutide was evaluated in the clinical trial called SCALE (Satiety and Clinical Adiposity: Evidence for liraglutide), where it was determined that a dosage of 3.0 mg induced an 8% weight loss equivalent to 8.4 kg of the initial weight in over 56 weeks

Breast milk and solid food shaping intestinal immunity

As a result, the ECM transitions from a supportive scaffold to a pathological regulator of hepatic injury and fibrogenesis

The researchers noted that further research is needed to elucidate the exact pathophysiological mechanisms involved and to understand the trade-offs between the benefits and risks of GLP-1 receptor agonists

Recent Progress in Ferroptosis inducers for Cancer therapy